Share this article Share this article HAIFA, Israel, Feb. 4, 2021 /PRNewswire/ -- proteanTecs, a leading provider of health and performance monitoring solutions for advanced electronics, announced today the appointment of former Optimal+ (acquired by National Instruments) executive, Uzi Baruch, as chief strategy officer. Uzi Baruch appointed CSO of proteanTecs Mr. Baruch brings nearly twenty years of software development and business leadership experience, managing R&D teams and high scale projects at leading, global hi-tech companies. He joined Optimal+ in 2015 as VP of R&D and was instrumental in driving the company's big data offering, enabling customers to innovate manufacturing through a data-centric approach. Beginning of 2019, Mr. Baruch assumed the General Manager responsibility of Optimal+'s new growth business, leading the Automotive and Electronics Business Unit until the acquisition of Optimal+ by National Instruments. Before joining Optimal+, Mr. Baruch served as VP of R&D in the Enterprise Group at NICE.